Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add filters








Year range
1.
Journal of Sun Yat-sen University(Medical Sciences) ; (6): 260-267, 2020.
Article in Chinese | WPRIM | ID: wpr-817703

ABSTRACT

@#【Objective】To evaluate the protective effect of Scutellarin(SCU)on type II diabetes-induced disorder of testes and show the mechanism of Scutellarin′s action.【Method】We divided 24 Wistar rats equally into 3 groups:control group,diabetes group and diabetes + SCU group. We used streptozotocin and high-fat diet to establish type Ⅱ diabetic rat model on Wistar rat. Haematoxylin and eosin staining were used to evaluate the testicular morphologic changes. Immunohistochemical staining was used to measure the expression level of vascular endothelial growth factor(VEGF)in testes. Oxidative stress in testes and epididymis was tested by fluorescence spectrophotometer and enzyme linked immunosorbent assay(ELISA). The blood flow rate in testicular vessels was measured by Doppler. 【Results】 Our results showed that hyperglycemia induced morphologic impairments in testes of rats, higher concentrations of Malondialdehyde(MDA) and ROS in testes and epididymis, lower testicular blood flow rate, while administration of Scutellarin could significantly inhibit these damages(DCF:12.93 vs. 7.63 mg/min ;MDA:2.37 vs. 1.48 mg/min ;testicular blood flow rate:110.0 vs. 210.2 mm/s;P < 0.05).【Conclusion】Our data suggest that SCU has the potential to reverse male reproductive disorder in diabetes by reducing the concentrations of ROS and improving. microcirculatory disturbances.

2.
China Pharmacy ; (12): 2968-2972, 2019.
Article in Chinese | WPRIM | ID: wpr-817478

ABSTRACT

OBJECTIVE: To study the hypoglycemic effect and mechanism of Zicui yin on type Ⅱ diabetic rats, and to provide theoretic basis for clinical application. METHODS: Eighty male rats were fed with high fat/sugar diet for 4 weeks, and then given intraperitoneal injected with streptozotocin (35 mg/kg) to induce type 2 diabetic model. Other 10 rats were included in normal group. Model rats were randomly divided into metformin group (positive control, 0.2 g/kg), model group (constant volume of distilled water), Zicui yin high-dose, medium-dose, low-dose groups (14.0, 7.0, 3.5 g/kg), with 10 rats in each group. After 2 weeks of continuous intragastic administration, the fasting blood glucose of rats in each group was measured by automatic blood glucose meter. The serum insulin level was determined by ELISA. mRNA expression of JNK, Akt and IRS-1 were detected by RT-PCR; The phosphorylation of JNK, Akt and IRS-1 proteins in the pancreatic tissue of rats in each group was detected by Western blot method. RESULTS: Compared with normal group, the fasting blood glucose, mRNA expression of JNK, The phosphorylation of JNK and IRS-1 proteins in the pancreatic tissue of the model group were significantly increased (P<0.05 or P<0.01), while the serum insulin content, mRNA expression of Akt and IRS-1, the phosphorylation of Akt protein were significantly decreased (P<0.01). Compared with model group, the fasting blood glucose of rats in metformin group and Zicui yin high-dose and middle-dose groups decreased significantly (P<0.05), the serum insulin content of rats in both metformin group and Zicui yin high-dose group increased significantly (P<0.01), and mRNA expression of JNK in pancreatic tissue of rats in metformin group and Zicui yin groups decreased significantly (P<0.01), while mRNA expression of Akt and IRS-1 increased significantly (P<0.01). The phosphorylation of JNK and IRS-1 proteins in metformin group and Zicui yin high-dose group decreased significantly (P<0.01), while the phosphorylation of        Akt protein were increased significantly (P<0.01). CONCLUSIONS: Zicui yin can significantly reduce blood glucose level, the mechanism of which may be related to decreasing the phosphorylation of JNK and IRS-1 proteins and increasing the phosphorylation of Akt proteins in pancreatic islets.

3.
China Pharmacist ; (12): 989-991, 2018.
Article in Chinese | WPRIM | ID: wpr-705645

ABSTRACT

Objective: To study the hypoglycemic effect and the hypodermic injection irritation of exendin multiple emulsion in tes-ting animals. Methods: Using normal saline and blank multiple emulsion as the blank controls and the marketed exendin injection as the positive control, the hypoglycemic effects of exendin multiple emulsion in healthy mice and mice with gastric administration of 10% glucose solution were studied. Type Ⅱ diabetes rat model was established, and the hypoglycemic effect of exendin multiple emulsion was investigated. The injection of local skin was observed and the slides of injection tissue were studied after HE staining to evaluate the irritation of exendin multiple emulsion. Results: In the healthy mice, the blood glucose reached the lowest point at 90min for ex-endin injection and rose gradually at 120 min, while the blood glucose maintained low levels during the testing period for exendin multi-ple emulsion. After the gastric administration of glucose solution, the blood glucose increased at 60min for exendin injection, while that kept low levels for exendin multiple emulsion. In type Ⅱ diabetes rats, the blood glucose increased gradually after 7-day withdrawal (P<0. 05), while that kept low levels for exendin multiple emulsion. The hypodermic injection of exendin multiple emulsion showed no significant or irreversible irritation to the local skin and tissue. Conclusion: Compared with exendin injection, exendin multiple emul-sion exhibits stable and sustained hypodermic effects with high local use safety.

4.
Chinese Pharmacological Bulletin ; (12): 917-924, 2018.
Article in Chinese | WPRIM | ID: wpr-705153

ABSTRACT

Aim To study the anti-diabetic effects of natural product gastrodin ( GSTD ) in KK-Ay mice. Methods C57BL/6J mice were used as normal con-trol, while KK-Ay diabetic mice were divided into five groups, namely the untreated group, GSTD 10 mg· kg-1, 20 mg·kg-1, 50 mg·kg-1 groups, and the metformin ( Met) 200 mg·kg-1 group, respectively, with 10 mice in each group. GSTD and Met were ad-ministered intragastrically for eight weeks. Before ex-periment and once a week during the experiment, the fasting blood glucose ( FBG) levels were determined. During the 7th week of drug treatment, oral glucose tolerance test ( OGTT ) and insulin tolerance test ( ITT) were conducted. Before the end of experiment, 24 h urine samples were collected for the assay of rela-tive parameters. At the end of experiment, blood sam-ples were collected for the assay of glycosylated hemo-globin ( GHb) ; serums were isolated for the determina-tion of insulin concentration and other biochemical in-dexes. After sacrifice, the livers, kidneys, and pan-creases of the mice were harvested for pathological ex-amination; the contents of advanced glycation end product ( AGE) and triglyceride ( TG) in renal tissues were assayed by kits. Results GSTD at all doses sig-nificantly reduced FBG, urine glucose, GHb, serum insulin level, and the insulin resistance index in KK-Ay diabetic mice. In addition, GSTD greatly inhibited body weight gain and improved glucose tolerance and insulin tolerance ( P <0.05 or P <0.01 vs untreated group ) . The pathological examination showed that GSTD significantly increased the glycogen content of liver tissues, reduced islet volume and improved its pathological changes. In addition, the glomerulosclero-sis induced by diabetes was greatly ameliorated by GSTD. Meanwhile, GSTD greatly reduced serum crea-tine ( Scr) , 24 h urine amount, 24 h urine total pro-tein and microalbumin ( mAlb) , as well as renal AGE and TG contents in KK-Ay mice ( P <0.05 or P <0.01 vs untreated group) . The anti-diabetic effect of GSTD at 50 mg·kg-1 was comparable to that of 200 mg·kg-1 of Met. Conclusions When used to treat KK-Ay diabetic mice, GSTD has potent activities in lowering blood glucose, improving insulin resistance and ameliorating diabetic nephropathy. However, the detailed mechanisms of GSTD in modulating glucose metabolism and increasing insulin sensitivity still need further investigation.

5.
Chinese Journal of Digestive Surgery ; (12): 43-46, 2017.
Article in Chinese | WPRIM | ID: wpr-505335

ABSTRACT

With the rapid development of minimally invasive techniques,the emergence of three-dimensional (3D) laparoscope leading minimally invasive surgical accessPrecise Time.In the past 60 years,bariatric surgery provides a large number of clinical evidences to confirm:metabolic and bariatric surgery is lasting and effective for obesity combined with type 2 diabetes mellitus (T2DM),and it is also the best treatment method for T2DM.The author believes that 3D laparoscopic system can help beginners quickly master laparoscopic surgical techniques and shorten the learning curve to master the technical points.Compared with two-dimensional (2D) laparoscopic surgery,3D laparoscopic stereo vision can help experienced bariatric surgeons shorten operation time which is related to surgical procedures.The shorter surgical procedure in laparoscopic sleeve gastrectomy is hardly affecting the operation time.Because gastric bypass surgery is relatively complex,3D laparoscopic techniques which are fully utilized in gastric bypass surgery can effectively shorten the operation time.

6.
Journal of Kunming Medical University ; (12): 82-85, 2016.
Article in Chinese | WPRIM | ID: wpr-509719

ABSTRACT

Objective To investigate the relationship between thyroid hormone and uric acid (UA) and body mass index (BMI) in patients with type Ⅱ diabetes and normal thyroid function.Methods Total of 313 patients with type Ⅱ diabetes and normal thyroid function were selected.BMI,fasting blood glucose (FBG),the metabolism of blood lipid,thyroid hormones and UA indicators were examined and the correlations of thyroid hormone,BMI and UA were analyzed.Results (1) The patients were divided into two groups according to gender,and FT3,FT4,and UA of male were found to be significantly higher than those in female (P<0.01).TSH,SBP,HDL-C in female were significantly higher than those in male (P<0.01);(2) The patients were divided into three groups according to BMI Level.Thyroid-stimulating hormone (TSH),three iodine armour gland original glycine (TT3),free three iodine thyroid glycine (FT3),UA,and FBG in overweight and obesity groups were found to be higher than those in normal weight group (P < 0.05);(3) The patients were divided into two groups according to the TSH level.Serum uric acid,TT3,FT3,fasting insulin in the group with TSH above 2.5 uIU/L were found to be higher than those in the group with TSH under 2.5 uIU/L (P < 0.05);(4) Patients were divided into two groups according to the UA level.TSH,FT3 in male with high uric acid were found to be higher than those in male with normal uric acid (P < 0.05);TSH was in female with high uric acid was found to be higher than that in female with normal uric acid (P < 0.05).Conclusion Thyroid hormone in patients with type Ⅱ diabetes can be used to assess the body weight and uric acid,which is of great clinical importance.

7.
Chinese Pharmacological Bulletin ; (12): 603-606,607, 2016.
Article in Chinese | WPRIM | ID: wpr-604050

ABSTRACT

Metabolic syndrome is the fundamental factor in the pathogenesis of a variety of diseases, and it has not yet been fully understood due to its complicated mechanism. Multiple re-searches have implicated that Wnt/β-catenin signaling pathway may have a significant effect on the formation and development of metabolic syndrome. LRP6 is an important co-receptor of Wnt/β-catenin signaling pathway ,and there are some researches im-plicating the correlation between LRP6 and metabolic syndrome. The in-depth research on the gene polymorphism and its modula-tion mechanism can provide new ideas and directions for meta-bolic syndrome therapy.

8.
Chinese Journal of Clinical Pharmacology and Therapeutics ; (12)2004.
Article in Chinese | WPRIM | ID: wpr-555220

ABSTRACT

AIM: To investigate the alteration of the vascular response to contracting material and the endothelium dependent vascular relaxation (EDVR) at different stages of type Ⅱ diabetes rats. METHODS: Type Ⅱ diabetes rat model was established by high-energy diet and lower dose of STZ. At 12th and 20th weekends after injecting STZ, the vascular reactivities to phenylephrine (PHE) and KCl and the EDVR induced by Ach were measured respectively in the isolated aorta rings. RESULTS: At 12th weekend after injecting STZ, the response to PHE increased, the reactivity to KCl kept unchanged, and the EDVR was damaged lightly. But at the 20 th weekend after injecting STZ, the response to PHE increased further and the reactivity to KCl markedly reinforced, and the EDVR was obviously damaged. CONCLUSION: The response of great vessels to contracting material increased, but the EDVR attenuated at different stages of type Ⅱ diabetes rats. These changes are further reinforced along with the developing of disease duration.

9.
Journal of Third Military Medical University ; (24)2003.
Article in Chinese | WPRIM | ID: wpr-678842

ABSTRACT

Objective To investigate the changes of bone mineral density (BMD) and its causing factors in menopausal female patients with type Ⅱ diabetes mellitus (DM2). Methods Dual energy X ray absorptimetry was used to measure the BMD of lumbar spines (L 2-4 ) and proximal femur in 82 female patients with type Ⅱ diabetes and 46 normal controls. According to BMD, DM2 patients were divided into two groups (DM A and DM B). Fasting plasma glucose (FPG), fasting plasma insulin (FINS), fasting plasma C peptide (FCP), glycated hemoglobin (HbAc1), urine albumin excretion rate (UAER), and urine ? 2 microglobin (? 2 MG) were measured and compared between the two groups. Results BMD of lumbar spines (L 2-4 ), femoral neck and Ward's triangle in diabetic patients were significantly lower than that of the controls ( P

10.
Chinese Journal of Clinical Pharmacology and Therapeutics ; (12): 38-40, 2001.
Article in Chinese | WPRIM | ID: wpr-411914

ABSTRACT

AimTo study the effects of glipizide and met formin on the serum IGF-1,IGF-2 in patients with type Ⅱ diabetes mellitus; Methods The effect of glipizide(n = 40) and metformin(n = 25) on serum IGF-1, IGF-2 in patients with type Ⅱ diabetes mellitus were compared with self- controlled study. Results In metformin-treated patients ,there were not significantly changes in fasting IGF-1 and IGF-2 concentrations, In glipizide-treated patients, there were markedly increased IGF-1 concentrations(181.8+ 104.5) vs (209.0+ 88.2) ng· ml-1(P<0.05) while serum IGF-2 was not change. There was a significant reduction of blood glucose in two groups at the end of treatment(both P<0.01), but C-peptide level was markedly increased(P<0.05) only in glipizide-treatedpatients.Conclusion The changes of IGF-1 is markedly different between metformin-treated and glipizide-treated patients with type Ⅱ diabetes mellitus.

11.
China Pharmacy ; (12)2001.
Article in Chinese | WPRIM | ID: wpr-529089

ABSTRACT

OBJECTIVE: To observe the effects of Spleen- strengthening decoction on GLP- 1 in patients with type II diabetes. METHODS: A randomized double- blind placebo- controlled test was conducted, and through observations for 8 wks, the changes of the two patient groups in plasma glucose, HbA1c, plasma GLP- 1 and Glucagon as well as TCM symptom score were measured for comparison. RESULTS: Before administration of Spleen- strengthening decoction, the two groups showed no significant difference in all of the indexes. After administration, the treatment group recorded lower indexes in fasting plasma glucose, HbA1c and plasma Glucagon, but higher index in fasting plasma GLP- 1, with no significant difference seen in other indexes. CONCLUSIONS: Spleen- strengthening decoction can improve glucose metabolism through heightening fasting plasma GLP- 1, and lowering both Glucagon and fasting plasma glucose.

12.
Chinese Journal of Clinical Pharmacology and Therapeutics ; (12)2000.
Article in Chinese | WPRIM | ID: wpr-677328

ABSTRACT

Aim To study the effects of glipizide and metformin on the serum IGF_1,IGF_2 in patients with type Ⅱ diabetes mellitus;Methods The effect of glipizide(n=40) and metformin(n=25) on serum IGF_1,IGF_2 in patients with type Ⅱ diabetes mellitus were compared with self_ controlled study.Results In metformin_treated patients ,there were not significantly changes in fasting IGF_1 and IGF_2 concentrations,In glipizide_treated patients,there were markedly increased IGF_1 concentrations (181.8?104.5) vs (209.0?88.2) ng?ml-1(P

13.
Chinese Pharmacological Bulletin ; (12)1987.
Article in Chinese | WPRIM | ID: wpr-677798

ABSTRACT

Peroxisome proliferator activated receptor(PPAR), a member of the hormone receptor superfamily, is a key regulating factor in adipocyte differentiation and lipids metabolism. Recently, with the increased understanding of the precise mechanisms of TZD, thiazolidinedione class of insulin sensitizer, PPAR? has also been identified as the major functional receptor for the drugs. In the study of the relationship between PPAR and insulin resistance, considerable gaps appeared. TZD induced activation of PPAR? is known to promote insulin sensitivity. More interestingly, however, PPAR? +/- heterozygous mice were shown to be less susceptible to insulin resistance. These findings suggest that the relationship between PPAR activation and insulin sensitivity improvement is not simplely positively related. A better understanding of the role of PPAR in insulin action system will be critical in developing more efficacious and safe agents that act on PPAR and benefit patients with type 2 diabetes.

SELECTION OF CITATIONS
SEARCH DETAIL